Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study
Received 2 September 2020
Accepted for publication 13 October 2020
Published 29 October 2020 Volume 2020:16 Pages 2569—2577
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Roger Pinder
Naomichi Okamoto,1 Keita Watanabe,2 LeHoa Ngyuyen,1,3 Atsuko Ikenouchi,1 Taro Kishi,4 Nakao Iwata,4 Shingo Kakeda,5 Yukunori Korogi,6 Reiji Yoshimura1
1Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan; 2Open Innovation Institute, Kyoto University, Kyoto, Japan; 3School of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam; 4Department of Psychiatry, Fujita Medical University, Toyoake, Japan; 5Department of Radiology, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan; 6Department of Radiology, University of Occupational and Environmental Health, Kitakyushu, Japan
Correspondence: Reiji Yoshimura
Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Fukuoka 8078555, Japan
Tel +81 936917253
Purpose: The kynurenine (KYN) pathway can directly or indirectly influence cerebral volume and neural integrity in patients with major depression (MD). The aim of the present study was to investigate neural network systems and the KYN pathway in patients with first-episode, drug-naïve MD.
Patients and Methods: Twenty right-handed drug-naïve patients, with MD diagnosed using the Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition, Text Revision, Research Version, were included in this study. Magnetic resonance imaging scans and scores on the Hamilton Rating Scale for Depression were assessed, and serum sampling was performed prior to the start of pharmacological treatment. Image processing and data analysis were performed according to our recently published procedure. Serum metabolomes were measured in the cation and anion modes of CE-FTMS-based metabolome analysis.
Results: We found that serum KYN levels were positively correlated with the Z-scores of the salience network but not with those of the central executive network or default mode network. No associations were observed between serum glutamate levels and the Z-score of any of the three networks.
Conclusion: Our results indicate that serum KYN levels might affect the activity of the salience network in first-episode, drug-naïve patients with MD.
Keywords: kynurenine, major depression, neural network, source-based morphometry
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]